Last quarter (Q4 2023), Coherus Biosciences's total revenue was $91.52M, an increase of 101.92% from the same quarter last year. In Q4, Coherus Biosciences's net income was $-79.65M. See Coherus Biosciences’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 224.81M	$ 257.24M	$ 211.04M	$ 326.55M	$ 475.82M	$ 356.07M
Cost of Revenue	$ 158.99M	$ 158.99M	$ 70.08M	$ -57.59M	$ 37.67M	$ 17.08M
Gross Profit	$ 65.82M	$ 98.25M	$ 140.96M	$ -57.59M	$ 438.16M	$ 338.99M
Operating Expense	$ 301.45M	$ 301.45M	$ 397.84M	$ 532.82M	$ 281.84M	$ 231.22M
Operating Income	$ -235.63M	$ -203.20M	$ -256.88M	$ -590.41M	$ 156.32M	$ 107.77M
Net Non Operating Interest Income Expense	$ -40.54M	$ -40.54M	$ -32.47M	$ -22.96M	$ -21.17M	$ -17.60M
Other Income Expense	$ -37.91M	$ -5.47M	$ 2.40M	$ -326.27M	$ 554.00K	$ 2.61M
Pretax Income	$ -238.27M	$ -238.27M	$ -291.75M	$ -287.10M	$ 135.71M	$ 92.78M
Tax Provision	$ -380.00K	$ -380.00K	-	-	$ 3.46M	$ 2.94M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -237.89M	$ -237.89M	$ -291.75M	$ -287.10M	$ 132.24M	$ 89.83M
Basic EPS	$ -2.57	$ -2.53	$ -3.76	$ -3.81	$ 1.85	$ 1.29
Diluted EPS	$ -2.57	$ -2.53	$ -3.76	$ -3.81	$ 1.62	$ 1.23
Basic Average Shares	$ 376.65M	$ 94.16M	$ 77.63M	$ 75.45M	$ 71.41M	$ 69.68M
Diluted Average Shares	$ 376.65M	$ 94.16M	$ 77.63M	$ 75.45M	$ 83.49M	$ 73.19M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	$ 2.47	-
Reported Normalized Diluted E P S	-	-	-	-	$ 2.16	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 460.44M	$ 460.44M	$ 467.92M	$ 475.23M	$ 319.50M	$ 248.30M
Net Income From Continuing And Discontinued Operation	$ -237.89M	$ -237.89M	$ -291.75M	$ -287.10M	$ 132.24M	$ 89.83M
Normalized Income	$ -137.19M	$ -238.65M	$ -230.49M	-	$ 132.24M	$ 89.83M
Interest Expense	-	-	-	-	$ 21.17M	$ 17.60M
EBIT	$ -197.73M	$ -197.73M	$ -259.28M	$ -264.14M	$ 156.87M	$ 110.38M
EBITDA	$ -194.58M	$ -194.58M	$ -249.15M	$ -255.29M	$ 159.76M	$ 113.64M

Currency in USD

Coherus Biosciences Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing